ANASTASIS BIOTEC LIMITED
Research and experimental development on biotechnology
ANASTASIS BIOTEC LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
56 Haverstock Hill Haverstock Hill London NW3 2BH United Kingdom
Full company profile for ANASTASIS BIOTEC LIMITED (10502511), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 29 Nov 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2017–2024)
Cash in Bank
£78.33k
Net Assets
£84.31k
Total Liabilities
£83.11k
Turnover
N/A
Employees
3
Debt Ratio
50%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Christina Andrea Kousparou | Director | Cypriot | Cyprus | 6 Feb 2024 | Active |
See all 7 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Agamemnon Antoniou Epenetos
British
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 31 Dec 2025 | Capital | Allotment of shares (GBP 35,173.94) on 29 Oct 2025 | |
| 19 Nov 2025 | Accounts | Annual accounts made up to 31 Dec 2024 | |
| 7 Nov 2025 | Confirmation Statement | Confirmation statement made on 7 Nov 2025 with updates | |
| 7 Oct 2025 | Capital | Allotment of shares (GBP 35,162.43) on 1 Sept 2025 | |
| 9 Jul 2025 | Officers | Termination of Mahendra Persaud Deonarain as director on 22 May 2025 |
Allotment of shares (GBP 35,173.94) on 29 Oct 2025
Annual accounts made up to 31 Dec 2024
Confirmation statement made on 7 Nov 2025 with updates
Allotment of shares (GBP 35,162.43) on 1 Sept 2025
Termination of Mahendra Persaud Deonarain as director on 22 May 2025
Recent Activity
Latest Activity
Allotment of shares (GBP 35,173.94) on 29 Oct 2025
4 months ago on 31 Dec 2025
Annual accounts made up to 31 Dec 2024
5 months ago on 19 Nov 2025
Confirmation statement made on 7 Nov 2025 with updates
5 months ago on 7 Nov 2025
Allotment of shares (GBP 35,162.43) on 1 Sept 2025
6 months ago on 7 Oct 2025
Termination of Mahendra Persaud Deonarain as director on 22 May 2025
9 months ago on 9 Jul 2025